X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE GSK PHARMA SUVEN LIFE/
GSK PHARMA
 
P/E (TTM) x 18.6 59.7 31.2% View Chart
P/BV x 3.7 11.2 33.4% View Chart
Dividend Yield % 0.6 2.6 23.7%  

Financials

 SUVEN LIFE   GSK PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
GSK PHARMA
Mar-18
SUVEN LIFE/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs2512,760 9.1%   
Low Rs1552,040 7.6%   
Sales per share (Unadj.) Rs49.1339.0 14.5%  
Earnings per share (Unadj.) Rs9.741.4 23.5%  
Cash flow per share (Unadj.) Rs11.445.9 24.8%  
Dividends per share (Unadj.) Rs1.5035.00 4.3%  
Dividend yield (eoy) %0.71.5 50.7%  
Book value per share (Unadj.) Rs60.3242.9 24.8%  
Shares outstanding (eoy) m127.2884.70 150.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.17.1 58.3%   
Avg P/E ratio x20.957.9 36.0%  
P/CF ratio (eoy) x17.852.3 34.1%  
Price / Book Value ratio x3.49.9 34.1%  
Dividend payout %15.484.5 18.3%   
Avg Mkt Cap Rs m25,825203,280 12.7%   
No. of employees `0001.1NA-   
Total wages/salary Rs m6135,234 11.7%   
Avg. sales/employee Rs Th5,832.6NM-  
Avg. wages/employee Rs Th571.5NM-  
Avg. net profit/employee Rs Th1,153.8NM-  
INCOME DATA
Net Sales Rs m6,25328,715 21.8%  
Other income Rs m233545 42.7%   
Total revenues Rs m6,48529,260 22.2%   
Gross profit Rs m1,9825,059 39.2%  
Depreciation Rs m213380 56.1%   
Interest Rs m462 2,315.0%   
Profit before tax Rs m1,9555,222 37.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0178 0.0%   
Tax Rs m7181,892 38.0%   
Profit after tax Rs m1,2373,508 35.3%  
Gross profit margin %31.717.6 179.9%  
Effective tax rate %36.736.2 101.4%   
Net profit margin %19.812.2 161.9%  
BALANCE SHEET DATA
Current assets Rs m5,62221,815 25.8%   
Current liabilities Rs m1,16815,999 7.3%   
Net working cap to sales %71.220.3 351.7%  
Current ratio x4.81.4 353.1%  
Inventory Days Days8164 128.0%  
Debtors Days Days3619 192.3%  
Net fixed assets Rs m3,32512,475 26.7%   
Share capital Rs m127847 15.0%   
"Free" reserves Rs m7,54719,726 38.3%   
Net worth Rs m7,67420,573 37.3%   
Long term debt Rs m146 231.7%   
Total assets Rs m9,13539,475 23.1%  
Interest coverage x43.22,612.0 1.7%   
Debt to equity ratio x00 621.1%  
Sales to assets ratio x0.70.7 94.1%   
Return on assets %14.08.9 158.0%  
Return on equity %16.117.1 94.5%  
Return on capital %26.026.2 99.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,066564 898.2%   
Fx outflow Rs m2,0017,429 26.9%   
Net fx Rs m3,065-6,865 -44.6%   
CASH FLOW
From Operations Rs m6994,728 14.8%  
From Investments Rs m-6-1,042 0.6%  
From Financial Activity Rs m-577-3,066 18.8%  
Net Cashflow Rs m116620 18.8%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 0.0 10.2 -  
FIIs % 0.0 23.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 15.4 237.0%  
Shareholders   37,287 102,036 36.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   ALEMBIC LTD  SUN PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  SHASUN PHARMA  

Compare SUVEN LIFE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 260 Points Down; TCS & Infosys Top Losers(12:30 pm)

Stock markets in India are presently trading lower, tracking weakness in their global peers. Among the sectoral indices, IT stocks and metal stocks are witnessing maximum selling pressure.

Related Views on News

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 22.7% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 22.7% YoY). Sales on the other hand came in at Rs 8 bn (down 2.4% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Nov 21, 2018 03:35 PM

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS